Bridion 200 mg/2 ml, Injektionslösung

7680585090011 CH-58509 Injektionslösung
Bridion 200 mg/2 ml, Injektionslösung
Bridion 200 mg/2 ml, Injektionslösung
1 / 2
google

Article details

Package size
10
Selling units
10
Measure
Ampulle(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/09/2022
Summary of Product Characteristics
Français
13/09/2022
Summary of Product Characteristics
Italien
13/09/2022

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
19.4 MG Substance HBESI

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
58509
Drug name
Bridion 100 mg/ml, Injektionslösung
Galenic form
LSPA
ATC Code
V03AB35
Authorization status
Z
Dispensing category
B
First authorization
07/01/2010
Authorization expiration date
31/12/9999
IT Number
15.01.0.
Domain
Human medicine
Field of application
Aufhebung der durch Recuronium oder Vecuronium induzierten neuromuskulären Blockade

Package details

Description (FR)
BRIDION 200 mg/2 ml sol inj 200 mg 10 pce
Description (DE)
BRIDION 200 mg/2 ml Inj Lös 200 mg 10 Stk
Market launch
07/01/2010
Narcotic (BTM)
No

Other package sizes (1)

BRIDION 500 mg/5 ml sol inj 500 mg 10 pce
10 AMP
GTIN: 7680585090028
View